Xartus AM Tablet is a combination antihypertensive medication containing Telmisartan 40mg and Amlodipine 5mg, indicated for the management of hypertension. Telmisartan, an angiotensin II receptor blocker (ARB), selectively inhibits the binding of angiotensin II to the AT1 receptor, thereby reducing vasoconstriction and aldosterone secretion, which leads to decreased blood pressure. Amlodipine, a dihydropyridine calcium channel blocker, inhibits calcium ion influx into vascular smooth muscle and cardiac muscle, promoting vasodilation and reducing peripheral vascular resistance. The synergistic effect of these two agents provides enhanced blood pressure control compared to monotherapy, improving cardiovascular outcomes and reducing the risk of stroke, myocardial infarction, and renal complications associated with hypertension. Xartus AM is typically administered once daily, with or without food, and dosage adjustments should be individualized based on patient response and tolerability. Common adverse effects may include dizziness, peripheral edema, headache, and fatigue. It is contraindicated in patients with hypersensitivity to either component, severe hepatic impairment, or pregnancy. Regular monitoring of blood pressure, renal function, and electrolytes is recommended during therapy. Xartus AM Tablet offers an effective and convenient option for patients requiring combination therapy for optimal hypertension management.